Skip to main navigation Skip to search Skip to main content

Cluster versus Firm-specific Factors in the Development of Dynamic Capabilities in the Pharmaceutical Industry in Ireland: A Study of Responses to Changes in Environmental Protection Regulations

  • Rachel M. Hilliard
  • , David Jacobson
  • DCU Business School

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

20 Citations (Scopus)

Abstract

Hilliard R. and Jacobson D. Cluster versus firm specific-factors in the development of dynamic capabilities in the pharmaceutical industry in Ireland: a study of responses to changes in environmental protection regulations, Regional Studies. This paper uses the evolutionary economic theory of the firm to examine the response of pharmaceutical manufacturing firms to changes in environmental regulations. Quantitative indicators of firms' learning and problem-solving are developed using data reported to the Irish Environmental Protection Agency (EPA). These are used to look at differences in capability between firms that are part of a pharmaceutical agglomeration and firms that are stand-alone. Analysis shows that spatial proximity may be a factor in firms' ability to implement both cleaner technology and the mandated managerial processes, but that the strength of problem-solving routines is also associated with firm-specific capabilities.

Original languageEnglish
Pages (from-to)1319-1328
Number of pages10
JournalRegional Studies
Volume45
Issue number10
DOIs
Publication statusPublished - Nov 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 8 - Decent Work and Economic Growth
    SDG 8 Decent Work and Economic Growth
  2. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Keywords

  • Cluster
  • Dynamic capability
  • Environmental regulation
  • Evolutionary economic geography
  • Management
  • Pharmaceutical industry

Fingerprint

Dive into the research topics of 'Cluster versus Firm-specific Factors in the Development of Dynamic Capabilities in the Pharmaceutical Industry in Ireland: A Study of Responses to Changes in Environmental Protection Regulations'. Together they form a unique fingerprint.

Cite this